From July 14, 2023 to September 30, 2023, the company has repurchased 16,019,740 shares, representing 0.82% for CNY 73.94 million. With this, the company has completed the repurchase of 16,019,740 shares, representing 0.82% for CNY 73.94 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 CNY | +0.50% | +2.27% | -8.78% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.78% | 1.07B | |
+43.25% | 6.3B | |
-15.08% | 4.53B | |
-6.70% | 3.29B | |
+5.47% | 3.2B | |
+0.76% | 2.63B | |
+47.75% | 1.97B | |
-5.08% | 1.74B | |
+2.05% | 1.69B | |
-7.08% | 1.64B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.